Ryo Ko
7PUBLICATIONS
30CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Mar 04, 2026
Beamion PANTUMOR-1: rationale and design of a Phase II trial of zongertinib in HER2-overexpressed/amplified or HER2-mutant solid tumors.Alison M Schram, John J Park, Antoine Italiano
|Mar 16, 2023
CALML5 is a novel diagnostic marker for differentiating thymic squamous cell carcinoma from type B3 thymoma.Koichiro Kanamori, Kentaro Suina, Takehito Shukuya
|Dec 16, 2022
Clinical characteristics of adrenal insufficiency induced by pembrolizumab in non-small-cell lung cancer.Kana Kurokawa, Yoichiro Mitsuishi, Naoko Shimada
|Aug 12, 2022
Updated Analysis of NEJ009: Gefitinib-Alone Versus Gefitinib Plus Chemotherapy for Non-Small-Cell Lung Cancer With Mutated EGFR.Eisaku Miyauchi, Satoshi Morita, Atsushi Nakamura
|Oct 07, 2021
Dramatic, significant metabolic response to a one-time pembrolizumab treatment following a relapse of pre-existing organizing pneumonia in a patient with advanced non-small cell lung cancer: A case report.Motoyasu Kato, Mikiko Mori, Keita Miura
|Mar 25, 2021
Zinc-finger E-box-binding homeobox 1 (ZEB1) plays a crucial role in the maintenance of lung cancer stem cells resistant to gefitinib.Fariz Nurwidya, Fumiyuki Takahashi, Wira Winardi
Pageof 2
Frequent Collaborators
4 joint publications
Takehito Shukuya
1 joint publications
Fariz Nurwidya
1 joint publications
Daisuke Hayakawa
1 joint publications
Motoyasu Kato
1 joint publications
Eisaku Miyauchi
1 joint publications
Satoshi Morita
1 joint publications
Yukio Hosomi
1 joint publications
Satoshi Ikeda
1 joint publications
Toshiyuki Harada
1 joint publications
Koichi Hagiwara
